We are live on ! Find out more

Tilray

TLRY

Market cap $497M

3.36 USD

-0.18

5.08%

At close Updated Oct 12, 4:00 PM EDT

Pre-market

After hours

3.37

+0.01

0.3%

1 day

-5.08%

5 days

-10.16%

1 month

-18.84%

3 months

-24.66%

6 months

-50%

Year to date

-65.43%

1 year

-80.12%

5 years

-96.73%

10 years

-98.5%

About: Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.

Employees: 3,595

Healthcare Drug Manufacturers - Specialty & Generic

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 27.6%

Neutral 57.5%

Negative 14.9%

Tilray Q1: Not Looking Good, Remains A 'Hold'

Tilray reported disappointing fiscal Q1 results, missing revenue estimates despite management highlighting record sales. TLRY's revenue growth was driven solely by the BrewDog acquisition; core cannabis sales declined 13%, and the adjusted bottom line swung to a loss. Cash burn surged to $23.4 million, and share dilution remains severe, with shares outstanding up over 31% year-over-year.

Tilray Q1: Not Looking Good, Remains A 'Hold'

The Motley Fool

3 Huge Red Flags From Tilray's Q1 Earnings Report

Tilray's cash burn continues to be a big problem for investors. The business has been growing through acquisitions, and while that can boost the top line, it can also lead to significantly higher expenses.

3 Huge Red Flags From Tilray's Q1 Earnings Report

The Motley Fool

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

Canopy Growth is refining its focus on medical and adult-use markets while managing its U.S. expansion strategy through Canopy USA. Tilray Brands has diversified its revenue stream significantly through a large craft beer and beverage portfolio alongside its global cannabis operations.

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

The Motley Fool

3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices

Tilray's financial results have been weak for years. The company operates in an uncertain industry.

3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices

Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform

Tilray Brands TodayTLRYTilray Brands$3.44 -0.15 (-4.04%) As of 11:26 AM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$3.38▼$20.20Price Target$6.38Add to WatchlistWhen investors hear talk of U.S. cannabis reform, they often look at major Canadian operators.

Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform

Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript

Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript

Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript

Tilray Brands Q1 Earnings Call Highlights

Tilray Brands NASDAQ: TLRY reported record first-quarter revenue and gross profit, driven by its BrewDog acquisition, international cannabis growth and pharmaceutical distribution operations, while reaffirming fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million.

Tilray Brands Q1 Earnings Call Highlights

Proactive Investors

Tilray revenue rises as beverage business drives record quarterly sales

Tilray Inc (NASDAQ:TLRY), the cannabis and consumer products company, reported record first-quarter revenue of $257.1 million, up 23% from a year earlier, driven by strong growth in beverages and international markets. Gross profit rose 35% to $77.5 million, while gross margin expanded to 30% from 27%, as the company continued to improve profitability across its businesses.

Tilray revenue rises as beverage business drives record quarterly sales

Tilray Brands Not Dependent on Single Market, CEO Highlights Multiple Growth Engines

Tilray Brands Inc. (NASDAQ:TLRY) reported a first-quarter 2027 adjusted loss of 2 cents per share on Thursday, beating the consensus loss of 20 cents.

Tilray Brands Not Dependent on Single Market, CEO Highlights Multiple Growth Engines

24/7 Wall Street

Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease

A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company's following moved the wrong way. Tilray Brands shares are at $3.

Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease

See News Rankings

Price charts implemented using Lightweight Charts™